Millennium: The Takeda Oncology Company
Empowering the Business to Help Extend Lives
Millennium: The Takeda Oncology Company is a leading biopharmaceutical company focused exclusively on improving the treatment of cancer around the world.
The Prescription for Ailing Clinical Trials Management
The clinical trial management landscape at Millennium was a fragmented and siloed operating model of disparate databases, trackers and spreadsheets. This model was inefficient and unsustainable, and the company sought a scalable and centralized clinical trial management system (CTMS).
Millennium executed a full RFP cycle with three prospective vendors, but determined that Perficient's ASCEND solution and associated suite of documentation (installation and test scripts) and services provided the best overall value, while also helping to shorten the implementation cycle by positioning it at a higher starting ground.
The implementation of ASCEND addressed systemic operating inefficiencies, with respect to the siloed approach of the management and oversight of clinical study start-up, conduct, and close-out activities.
Delivering a Pre-Configured Solution with ASCEND
ASCEND, Perficient’s Oracle Accelerate solution, is a pre-configured and enhanced version of Oracle Siebel CTMS, a solution for the centralized management of global clinical trials. ASCEND is designed to make this world-class system affordable for organizations of all sizes. As the first and only CTMS accelerator in the Oracle Accelerate Solution program, ASCEND significantly reduces implementation costs and timeframes and includes robust capabilities found on many companies' wish lists.
The deployed solution includes standard ASCEND functionality plus enhancements as well as custom integrations with Millennium’s preferred clinical research organizations (CROs). Millennium’s version of ASCEND allows it to maintain full management and oversight of its ongoing clinical studies, and provides the ability to standardize information flow across multiple CROs.
Results
A Healthy CTMS Means a Healthier Business
The implementation of ASCEND addressed systemic operating inefficiencies, with respect to the siloed approach of the management and oversight of clinical study start-up, conduct, and close-out activities. The system now has key functionality around centralized and automated investigator safety letter distribution, as well as an elegant and robust data integration mechanism for XML data exchange with its CRO preferred partners.
With the successful installation and deployment of ASCEND, Perficient helped Millennium realize successes including:
- Cleansing and migration of identified legacy data into ASCEND
- Automated data integration streams with Millennium’s preferred CRO partners
- Project delivered on time and within budget
- User acceptance of ASCEND
- Business processes modified to include ASCEND
- Customization of CTMS technology to support business processes and adaptation of the business processes in response to CTMS technology where necessary
- End user training for production rollout
Examining the product, we realized that it met approximately 80% of our requirements out-of-the-box.Joe Coady, Informatics Project Lead, Millennium Pharmaceuticals
